Biotech Association Asks MHLW to Include Drugs for Intractable Diseases and Orphan Drugs in Early Approval System

The SAMURAI Biotech Association (president: Ei Yamada, president of AnGes MG), a group consisting of 22 bioventure companies, submitted a petition on the amendment of the Pharmaceutical Affairs Law (PAL) and the NHI price system to Minister of Health, Labor...read more